When COVID-19 entered the United States, it felt like a scramble to figure out what our next steps were as a field. Do operations continue to give patients the best chance of success? Or do the risks outweigh the benefits? Some clinics pivoted quickly, following the ASRM guidelines precisely. And some clinics panicked with feelings of apprehension of stopping treatment all together.

On this episode of Inside Reproductive Health, Griffin talks to Dr. Oluyemisi (Yemi) Famuyiwa, the leader of a clinic who seemed to be well-prepared for the unknowns of the virus. Dr. Famuyiwa is the founder and director of Montgomery Fertility Center, an independent clinic located in Rockville, Maryland. Dr. Famuyiwa aims to provide state-of-the-art care based on emergent technologies and ongoing research. And this philosophy was truly exposed when COVID-19 first came on the radar.

Her ahead-of-the-game research got her clinic appropriately prepared for the emergence of the virus in her area, keeping volume steady--and even bringing it to the highest it has ever been. So what lessons can other clinics take from her experience in the COVID-19 era?

Learn more about Dr. Yemi Famuyiwa and Montgomery Fertility Center by visiting montgomeryfertilitycenter.com.

To get started on a marketing plan for your company, complete the Goal and Competitive Diagnostic at FertilityBridge.com.